2026 NPPES data Infectious Disease Physician NPI 1548215171 MD
Verify on CMS →

TASADUQ FAZILI, MD

Infectious Disease Physician in ROANOKE, Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
502
Medicare Part D claims · 77 beneficiaries · Infectious Disease Physician avg: 816
Generic prescribing
26%
generic claims · 74% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

TASADUQ FAZILI, MD filed 502 Medicare Part D claims in 2023 as a Infectious Disease Physician in ROANOKE, Virginia, prescribing 26% generic.

502
Part D claims, 2023
26%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

TASADUQ FAZILI, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

502 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

TASADUQ FAZILI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about TASADUQ FAZILI, MD?

Quality data not reported

NPI registry status

Active

Issued 05/23/2006

NPI 1548215171

Primary specialty

Infectious Disease Physician

Mid-sized

8,292 US NPIs in this specialty

Medicare Part D claims

502 38% vs specialty avg

2023 prescription claims

Specialty avg: 816

Specialty distribution in Virginia

How Infectious Disease Physician compares to other specialties among Virginia providers

Virginia providers

Infectious Disease Physician share within Virginia

1. Infectious Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Infectious Disease Physician share within Virginia

Specialty board-certification context

Estimated specialty board-certified rate — Infectious Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Infectious Disease Physician ABMS/AOA estimate

Est. board-certified rate (Infectious Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Infectious Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TASADUQ FAZILI, MD appears in the CMS NPPES registry as a Infectious Disease Physician provider holding MD credentials at 2001 CRYSTAL SPRING AVE SW STE 301, ROANOKE, VA, 24014, with a listed phone of (540) 981-7715. NPI 1548215171 was issued on 05/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FAZILI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 502 prescription claims written by this provider, covering 77 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 74% brand-name and 26% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Infectious Disease Physician is a mid-sized specialty nationwide, with 8,292 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2001 CRYSTAL SPRING AVE SW STE 301
ROANOKE, VA 24014

Provider Details

NPI 1548215171
Specialty Infectious Disease Physician
Credentials MD
Gender Male
NPI Issued 05/23/2006

Hospital and facility affiliations

Facilities where TASADUQ FAZILI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CARILION GILES COMMUNITY HOSPITAL
★★★★☆ 4/5
PEARISBURG, VA
Critical Access Hospitals
CMS CCN: 491302
CARILION MEDICAL CENTER
★★★☆☆ 3/5
ROANOKE, VA
Acute Care Hospitals
CMS CCN: 490024

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

TASADUQ FAZILI, MD — brand share 74.0%
Specialty average (est.)

74% brand-name claims vs 26% generic, on 502 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

502
Total Claims
$1.4M
Total Drug Cost
77
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
509
Total Day Supply
11,827
Brand vs Generic
74% brand / 26% generic
Brand Drug Cost
$1.3M
Generic Drug Cost
$81K
Antibiotic Claims
100

Patient Demographics

Average Patient Age
64.4 years
Avg HCC Risk Score
1.57
Gender Split
34% female / 66% male
Age Distribution
<65: 36, 65-74: N/A, 75-84: 19, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What TASADUQ FAZILI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Biktarvy
Bictegrav/Emtricit/Tenofov Ala
193
Genvoya
Elviteg/Cob/Emtri/Tenof Alafen
50
Sodium Chloride
0.9 % Sodium Chloride
33
Daptomycin
27
Triumeq
Abacavir/Dolutegravir/Lamivudi
22
Odefsey
Emtricitab/Rilpiviri/Tenof Ala
20
Valacyclovir
Valacyclovir Hcl
18
Ceftriaxone
Ceftriaxone Sodium
17
Juluca
Dolutegravir/Rilpivirine
13
Tivicay
Dolutegravir Sodium
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Infectious Disease Physician Overview

How TASADUQ FAZILI, MD fits within the Infectious Disease Physician landscape nationally.

8,292
Infectious Disease Physician Providers in US
54
States with Infectious Disease Physician
816
Avg Claims per Provider

TASADUQ FAZILI, MD's 502 claims are below the specialty average of 816.

Nearby Infectious Disease Physician Providers in Virginia

Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as FAZILI.

Compare Infectious Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TASADUQ FAZILI, MD's specialty?
TASADUQ FAZILI, MD specializes in Infectious Disease Physician and practices in ROANOKE, Virginia. Credentials: MD.
How much does TASADUQ FAZILI, MD prescribe under Medicare Part D?
In 2023, TASADUQ FAZILI, MD wrote 502 Medicare Part D claims totaling $1.4M in drug costs for 77 beneficiaries.
Where is TASADUQ FAZILI, MD located?
TASADUQ FAZILI, MD is located at 2001 CRYSTAL SPRING AVE SW STE 301, ROANOKE, VA, 24014. Phone: (540) 981-7715.
What is TASADUQ FAZILI, MD's NPI number?
TASADUQ FAZILI, MD's National Provider Identifier (NPI) is 1548215171, issued on 05/23/2006.
Does TASADUQ FAZILI, MD prescribe more brand-name or generic drugs?
TASADUQ FAZILI, MD's prescribing is 74% brand-name and 26% generic drugs by claim count, with $1.3M in brand drug costs.
How many Infectious Disease Physician providers are there in the US?
There are 8,292 Infectious Disease Physician providers across 54 states in the US. The average Infectious Disease Physician provider writes 816 Medicare Part D claims per year.
What drugs does TASADUQ FAZILI, MD prescribe most often?
Based on 2023 Medicare Part D data, TASADUQ FAZILI, MD's most frequently prescribed drugs include Biktarvy, Genvoya, Sodium Chloride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TASADUQ FAZILI, MD accept Medicare?
TASADUQ FAZILI, MD appears in CMS Medicare data with 502 Part D claims and 77 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TASADUQ FAZILI, MD's credentials?
TASADUQ FAZILI, MD's NPI is 1548215171 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology